MULTI DOSE DRUG VIAL ADAPTERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Multi Dose Drug Vial Adapters Market Size and Trends

The multi dose drug vial adapters market is estimated to be valued at USD 1,104.1 Mn in 2024 and is expected to reach USD 1,765.7 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031.

Discover market dynamics shaping the industry request sample copy

The multi dose drug vial adapters market is expected to witness significant growth over the forecast period. The rising prevalence of diseases like cancer, diabetes, and cardiovascular diseases globally is increasing the demand for multi-dose drug therapies. Moreover, the growing need to reduce healthcare costs by decreasing wastage of unused drugs is also supporting the growth of the multi dose drug vial adapters market.

Increasing Prevalence of Chronic Diseases

The growing prevalence of chronic diseases across the world has been a major factor driving the demand for multi-dose drug vial adapters. As per estimates by World Health Organization, chronic diseases accounted for almost 60% of worldwide deaths in 2020. Chronic diseases are long-term health conditions that require ongoing management over a period of time. Some of the most common chronic diseases include diabetes, cancer, heart disease, lung disease, strokes, etc. The treatment for chronic diseases often involves regular administration of drugs in the form of injections over a long period of time. This gives rise to the need for multi-dose vial adapters which help extract multiple doses from a single drug vial without contaminating the remaining contents. The increasing patient pool of chronic diseases worldwide is promoting the uptake of multi-dose vial adapters to efficiently draw multiple doses from a single vial for long-term medication management. Another factor is the growing geriatric population who are more prone to developing age-related chronic health conditions. This aging demographic is expected to surge the demand for adapters in the coming years.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Get instant access to report

The healthcare industry has seen a significant rise in self-administration of drugs and usage of home healthcare devices in recent years. This has been mainly driven by the convenience offered to patients and the reduction in hospital visits. As patients and caregivers are conducting more medical procedures at home, the need for adapters that can be used with multi-dose vials for self-injections or attachment with home healthcare devices has risen substantially. Multi-dose drug vial adapters provide a sterile barrier between the vial and the injection mechanism, preventing contamination. They help withdraw multiple doses from the vial for administration without touching the vial septum directly. This brings more safety and hygienic drug delivery. With growing preference for home treatment systems among patients with chronic diseases like diabetes, arthritis, etc., the demand for such adapters has surged rapidly. The COVID-19 pandemic has further accelerated this transition to home healthcare delivery. Hospital visits were restricted during pandemic peaks to avoid infections for non-critical cases. This pushed more treatment loads to home settings. Many patients continue preferring self-administration in the comfort of their homes even after pandemic restrictions are lifted. All these factors are expected to propel the multi dose drug vial adapters market even stronger in the future.

To learn more about this report, request sample copy

The availability of alternative drug delivery formats is posing a significant challenge for the growth of multi-dose drug vial adapters market. With advancements in drug delivery technologies, newer formats such as prefilled syringes and cartridges are gaining popularity among healthcare providers and patients. These alternative formats provide improved safety and more accurate dosing compared to vials that need to be accessed multiple times using an adapter. For instance, prefilled syringes eliminate the need for drawing up doses from a multidose vial and transferring it to the syringe. This reduces the risk of contamination compared to vial-and-syringe systems. They also allow for precise dosing and portioning of drugs. Similarly, cartridges provide a single-patient-use format that is less prone to dosing errors.

Market Opportunities – Emerging Markets in Developing Countries

Emerging markets in developing countries present a great opportunity for growth in the multi dose drug vial adapters market. With billions of people living in developing nations across Asia Pacific, Africa, and Latin America, there is massive potential for expanded access to healthcare. However, healthcare infrastructure and resources in these regions can be limited. Multi-dose vial adapters help address this challenge by enabling safe and effective administration of medication to multiple patients from a single vial. This prevents wastage and reduces costs significantly. As developing economies grow and their populations become more prosperous, the demand for advanced pharmaceutical products and healthcare services is expected to rise dramatically in the coming years.

Discover high revenue pocket segments and roadmap to it: Get instant access to report

The material type segment includes silicone, polycarbonate, and others. The polycarbonate segment is estimated to hold 41.4% share of the market in 2024 owing to its superior strength and durability characteristics. Polycarbonate adapters are highly resistant to breakage and deformation even under high pressure injections. Their tough nature ensures secure mounting of vials and prevents leakage. Compared to alternatives, polycarbonate can withstand higher temperatures without losing integrity. This makes it well-suited for frequently used multi-dose vials that may face elevated temperatures over multiple openings. Its lightweight yet robust construction also enhances ease-of-use for healthcare practitioners.

Insights, By Product Size: User-Friendly Systems Design Favors 20 Mm Adapters

The product size segment includes 13 mm, 20 mm, 28 mm, and others. The 20 mm sub-segment is expected to account for 33.1%% of the market share in 2024 owing to their ergonomic designs tailored for one-handed operation. Their diameters optimize grip and torque without compromising on volume capacities. The 20 mm size strikes an ideal balance between ease-of-access and accommodation of typical multi-dose volumes. Larger bore needles experience less resistance during withdrawal, ensuring smooth extractions. 20 mm adapters minimize hand fatigue for nurses through intuitive configurations. Their user-centric designs have made them the standard across major hospitals.

Insights, By End User: Infection Control Drives the Hospital Demand

The end user segment includes hospitals, ambulatory surgical centers, and others. The hospital sub-segment is expected to have 37.3% of the market share in 2024 due to stringent infection control norms. Healthcare regulators have mandated exclusive multi-dose vial access in hospitals to prevent cross-contamination. Adapters provide a barrier against accidental needle sticks and contamination between patients. Their needleless systems boost safety during injections from shared vials. Moreover, the large baseline needle usage in hospital settings drives procurement of U.S. Food and Drug Administration approved closed vial access devices. Adapters are indispensable tools for hospitals striving to comply with hygiene protocols and protect patients as well as staff.

Regional Insights

To learn more about this report, request sample copy

North America remains the dominant region in the global multi dose drug vial adapters market and is anticipated to hold 41.7% of the market share in 2024. North America has been the dominant region in the global multi dose drug vial adapters market. The U.S. accounts for the majority share owing to a well-established healthcare infrastructure and high adoption of advanced medical technologies. Major pharmaceutical companies have their headquarters in the U.S., driving extensive research and development activities in the country. This has resulted in the U.S. emerging as a key innovator with continuous introduction of novel drug vial adapters.

Asia Pacific market is poised to ascend at a substantial pace during the forecast period. China dominates the Asia Pacific multi dose drug vial adapters market attributing to its huge patient pool and enhancing healthcare infrastructure. The Chinese government's push for modernization of healthcare through increasing healthcare access and expenditure is fueling the market expansion. India is emerging as a fast-growing country due to expanding pharmaceutical manufacturing industry and rising medication usage. Moreover, improving economic conditions have boosted the per capita healthcare spending of people in India. This has augmented the demand for cutting-edge drug delivery tools like vial adapters from both hospitals and individuals. Therefore, the Asia Pacific region is anticipated to offer lucrative prospects for multi dose drug vial adapters market participants.

Market Report Scope

Market Segmentation

• Material Type Insights (Revenue, USD Mn, 2019 - 2031)
  • Silicone
  • Polycarbonate
  • Others
•  Product Size Insights (Revenue, USD Mn, 2019 - 2031)
  • 13 mm
  • 20 mm
  • 28 mm
  • Others
•  End User Insights (Revenue, USD Mn, 2019 - 2031)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
• Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • BD
  • B. Braun SE
  • Terumo Medical Corporation
  • Adelphi Group
  • Med-Vet International
  • West Pharmaceutical Services, Inc.
  • ICU Medical
  • Helapet Ltd.
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Miltenyi Biotec
  • Randox Laboratories Ltd. 
  • West Pharmaceutical Services, Inc.
  • Amsino International, Inc.
  • Medline Industries, LP.